Herbehandeling met gepegyleerde interferon-alfa-2b in combinatie met ribavirine gedurende langer dan 48 weken is niet onderzocht bij non-responders met genotype 1. ###>Retreatment duration greater than 48 weeks in non-responder patients with genotype 1 has not been studied with pegylated interferon alfa-2b and ribavirin combination therapy.